Epitope-specific evolution of human CD8+ T cell responses from primary to persistent phases of Epstein-Barr virus infection

被引:236
作者
Hislop, AD [1 ]
Annels, NE [1 ]
Gudgeon, NH [1 ]
Leese, AM [1 ]
Rickinson, AB [1 ]
机构
[1] Univ Birmingham, CRC Inst Canc Studies, Birmingham B15 2TT, W Midlands, England
关键词
Epstein-Barr virus; CD8(+) T lymphocytes; infectious' mononucleosis; kinetics; phenotype;
D O I
10.1084/jem.20011692
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Primary virus infection often elicits a large CD8(+) T cell response which subsequently contracts to a smaller memory T cell pool; the relationship between these two virus-specific populations is not well understood. Here we follow the human CD8(+) T cell response to Epstein-Barr virus (EBV) from its primary phase in infectious mononucleosis (IM) through to the persistent carrier state. Using HLA-A2.1 or B8 tetramers specific for four lytic cycle and three latent cycle epitopes, we find marked differences in the epitope-specific composition of the T cell populations between the two phases of infection. The primary response is dominated by lytic epitope specificities which are severely culled (and in one case extinguished) with resolution of the acute infection; in contrast latent epitope specificities are less abundant, if present at all, in acute IM but often then increase their percentage representation in the CD8 pool. Even comparing epitopes of the same type, the relative size of responses seen in primary infection does not necessarily correlate with that seen in the longer term. We also follow the evolution of phenotypic change in these populations and show that, from a uniform CD45RA(-)RO(+)CCR7-phenotype in IM, lytic epitope responses show greater reversion to a CD45RA(-)PO(-) phenotype whereas latent epitope responses remain CD45RA(-)RO(+) with a greater tendency to acquire CCR7. Interestingly these phenotypic distinctions reflect the source of the epitope as lytic or latent, and not the extent to which the response has been amplified in vivo.
引用
收藏
页码:893 / 905
页数:13
相关论文
共 50 条
  • [41] Cytotoxic large T-cell lymphoma with fulminant clinical course, CD8+ and CD56- phenotype, and its relation to Epstein-Barr virus:: a report of two cases
    Kagami, Y
    Sobue, R
    Ito, N
    Yatabe, Y
    Taji, H
    Suzuki, R
    Seto, M
    Ogura, M
    Suchi, T
    Morishima, Y
    Nakamura, S
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 1999, 70 (02) : 105 - 111
  • [42] The trend of Epstein-Barr virus DNA loads and CD8+ T lymphocyte numbers can predict the prognosis of pediatric liver transplant recipients with PTLD
    Wang, Kedi
    Xu, Dongjiang
    Gao, Yan
    Ma, Kaihui
    Zhao, Wen
    JOURNAL OF LABORATORY MEDICINE, 2025, 49 (01) : 38 - 45
  • [43] Computational Prediction and Identification of Epstein-Barr Virus Latent Membrane Protein 2A Antigen-Specific CD8~+ T-Cell Epitopes
    Bing Wang1
    2Department of Clinical Laboratory
    Cellular & Molecular Immunology, 2009, 6 (02) : 97 - 103
  • [44] Comprehensive Analysis of Epstein-Barr Virus LMP2A-Specific CD8+and CD4+T Cell Responses Restricted to Each HLA Class I and II Allotype Within an Individual
    Jo, Hyeong-A
    Hyun, Seung-Joo
    Hyun, You-Seok
    Lee, Yong-Hun
    Kim, Sun-Mi
    Baek, In-Cheol
    Sohn, Hyun-Jung
    Kim, Tai-Gyu
    IMMUNE NETWORK, 2023, 23 (02)
  • [45] Programmed death 1 is highly expressed on CD8+ CD57+ T cells in patients with stable multiple sclerosis and inhibits their cytotoxic response to Epstein-Barr virus
    Cencioni, Maria T.
    Magliozzi, Roberta
    Nicholas, Richard
    Ali, Rehiana
    Malik, Omar
    Reynolds, Richard
    Borsellino, Giovanna
    Battistini, Luca
    Muraro, Paolo A.
    IMMUNOLOGY, 2017, 152 (04) : 660 - 676
  • [46] Primary hepatic Epstein-Barr virus-associated CD30-positive peripheral T-cell lymphoma of cytotoxic phenotype
    Peng, Yue
    Cai, Junchao
    Yue, Changjun
    Qing, Xin
    EXPERIMENTAL AND MOLECULAR PATHOLOGY, 2016, 100 (01) : 207 - 211
  • [47] Human immunodeficiency virus type I-specific CD8+ T cell subset abnormalities in chronic infection persist through effective antiretroviral therapy
    Pohling, Julia
    Zipperlen, Katrin
    Hollett, Natasha A.
    Gallant, Maureen E.
    Grant, Michael D.
    BMC INFECTIOUS DISEASES, 2010, 10
  • [48] CD47 expression in Epstein-Barr virus-associated gastric carcinoma: coexistence with tumor immunity lowering the ratio of CD8+/Foxp3+ T cells
    Abe, Hiroyuki
    Saito, Ruri
    Ichimura, Takashi
    Iwasaki, Akiko
    Yamazawa, Sho
    Shinozaki-Ushiku, Aya
    Morikawa, Teppei
    Ushiku, Tetsuo
    Yamashita, Hiroharu
    Seto, Yasuyuki
    Fukayama, Masashi
    VIRCHOWS ARCHIV, 2018, 472 (04) : 643 - 651
  • [49] Selected amino acid change encoding Epstein-Barr virus-specific T cell epitope of the LMP2A gene in Japanese nasal NK/T cell lymphoma patients
    Nagamine, Masayoshi
    Kishibe, Kan
    Takahara, Miki
    Nagato, Toshihiro
    Ishii, Hideyuki
    Bandoh, Nobuyuki
    Ogino, Takeshi
    Harabuchi, Yasuaki
    INTERVIROLOGY, 2007, 50 (05) : 319 - 322
  • [50] Processing of a multiple membrane spanning Epstein-Barr virus protein for CD8+ T cell recognition reveals a proteasome-dependent, transporter associated with antigen processing-independent pathway
    Lautscham, G
    Mayrhofer, S
    Taylor, G
    Haigh, T
    Leese, A
    Rickinson, A
    Blake, N
    JOURNAL OF EXPERIMENTAL MEDICINE, 2001, 194 (08) : 1053 - 1068